PRIMECAP Management's position in Boston Scientific is currently worth $3.75 Billion. That's 3.01% of their equity portfolio (4th largest holding). The investor owns 2.42% of the outstanding Boston Scientific stock. The first Boston Scientific trade was made in Q1 2013. Since then PRIMECAP Management bought shares fifteen more times and sold shares on 33 occasions. The stake costed the investor $382 Million, netting the investor a gain of 883% so far.
… the SEC. The institutional investor bought 48,868 shares of … hedge funds and other institutional investors . Wall Street Analysts Forecast … on the stock....
Diamond Hill Capital Management Inc. decreased its position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 2.8% in the second quarter, accord...
Baldwin Investment Management LLC purchased a … $223,000. Other institutional investors and hedge funds also recently … about $32,000. Institutional investor...
When you consider healthcare stocks, do you automatically think of pharmaceutical companies? Most people do. However, some of the most significant gains over...